Abstract Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which can lead to acute …

Neutrophils are the most abundant circulating leukocytes in humans and the first immune
cells recruited at the site of inflammation. Classically perceived as short-lived effector cells …

Background and aims Severe manifestations of coronavirus disease 2019 (COVID-19) are
associated with alterations in blood cells that regulate immunity, inflammation, and …

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the 29
causative pathogen of Coronavirus disease 2019 (COVID-19), has resulted in over 650 30 …

Thrombosis remains a major problem in our society, manifesting across multiple
demographic groups and with high associated morbidity and mortality. Thrombus …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has been responsible for a devastating pandemic since March …

COVID-19 progression often involves severe lung injury, inflammation, coagulopathy, and
leukocyte infiltration into pulmonary tissues. The pathogenesis of these complications is …

Excessive infiltration of activated neutrophils is regarded as a predominant cause of tissue
injury in neutrophilic inflammation. Although programmed cell death like apoptosis …

Thromboinflammation or immunothrombosis is a concept that explains the existing link
between coagulation and inflammatory response present in many situations, such as sepsis …

MIS-C is a systemic inflammation disorder with poorly characterised immunopathological
mechanisms. We compared changes in the systemic immune response in children with MIS …